Back to search

Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity.

Data up to Jan 2025

Published1998
Citations51
References25

Total Citations Per Year

Abstract

References (25)

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

1993 • 2,828 citations

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

1992 • 551 citations

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.

1994 • 482 citations

Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules

1990 • 338 citations

Myeloma Proteins as Tumor-Specific Transplantation Antigens

1972 • 325 citations

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1993 • 314 citations

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo

1994 • 300 citations

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1995 • 269 citations

DNA immunization induces protective immunity against B–cell lymphoma

1996 • 252 citations

Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells

1991 • 250 citations

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

1996 • 232 citations

Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB origin

1977 • 169 citations

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

1987 • 168 citations

Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.

1990 • 144 citations

Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.

1987 • 142 citations

In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes.

1992 • 133 citations

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1975 • 128 citations

PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE

1974 • 75 citations

Induction of Secretion of IgM from Cells of the B Cell Line 38C-13 by Somatic Cell Hybridization

1979 • 70 citations

A Genetic Approach to Idiotypic Vaccination

1993 • 69 citations

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.

1994 • 61 citations

Immunization with the Light Chain and the VL Domain of the Isologous Myeloma Protein 315 Inhibits Growth of Mouse Plasmacytoma MOPC315

1980 • 40 citations

Europium-labelled streptavidin as a highly sensitive universal label

1992 • 40 citations

Interleukin‐2 in liposomes: Increased intravenous potency and less pulmonary toxicity in the rat

1992 • 37 citations

Participation of the Humoral Immune System in the Myeloma-Specific Transplantation Resistance

1978 • 30 citations

Cited By (0)

Loading...
Liposomal formulation of a self lymphoma antigen induces potent protective antitumor… (1998) – PubMed | Metascience Observatory Explorer